BRIEF-Neurizon Therapeutics Says Got Guidance From FDA Placing IND Application For NUZ-001 Under Clinical Hold
ReutersFeb 17, 2025 1:38 AM
Feb 17 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX:
GOT GUIDANCE FROM US FDA PLACING CO'S IND APPLICATION FOR NUZ-001 UNDER CLINICAL HOLD
Further company coverage: NUZ.AX
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
NVIDIA Q2 FY2026: Surfing the AI Surge with Blackwell, Steering Through China’s Export Challenges
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) reported strong Q2 FY2026 results on August 27, 2025, after market close, driven by robust AI-powered demand and adoption of its next-generation Blackwell GPU platform. The company delivered significant revenue and profit beats overall, with...TradingKey
2 hours ago
Spotting Signals for the Next Crypto Bull Run: Will Bitcoin Asia 2025 Deliver?
TradingKey - Markets were caught off guard last week when Fed Chair Jerome Powell struck a surprisingly dovish tone at Jackson Hole.TradingKey
22 hours ago
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
CrowdStrike Stock Falls 9% After Disappointing Guidance: Time to Buy the Dip?
TradingKey - Cybersecurity is a booming industry, but even the best stocks can hit speed bumps. That’s exactly what happened to CrowdStrike Holdings Inc (NASDAQ: CRWD) after the company released its latest earnings report.TradingKey
Wed, Mar 5
